Camelon 4/Camelon 8 Indications/Uses

Camelon 4: CAMELON 4 Tablets are indicated in the following conditions: Endocrine Disorders: Primary or secondary adrenocortical insufficiency (Hydrocortisone or Cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance.
Congenital adrenal hyperplasia; Non-suppurative thyroiditis; Hypercalcemia associated with cancer.
Rheumatic Disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy); Ankylosing spondylitis; Psoriatic arthritis; Acute and subacute bursitis; Epicondylitis; Synovitis of osteoarthritis; Acute gouty arthritis; Acute non-specific tenosynovitis; Post-traumatic osteoarthritis.
Collagen Diseases: During an exacerbation or as maintenance therapy in selected cases of: Systemic lupus erythematosus; Systemic dermatomyositis (polymyositis); Acute rheumatic carditis.
Dermatologic Diseases: Bullous dermatitis herpetiformis; Severe erythema multiforme (Stevens-Johnson syndrome); Severe seborrheic dermatitis; Exfoliative dermatitis; Pemphigus; Mycosis fungoides; Severe psoriasis.
Allergic States: Control of severe or incapacitating allergic condition intractable to adequate trials of conventional treatments: Seasonal or perennial allergic rhinitis; Drug hypersensitivity reactions; Serum sickness; Bronchial asthma; Contact dermatitis; Atopic dermatitis.
Ophthalmic Diseases: Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa, such as: Allergic corneal marginal ulcers; Herpes zoster ophthalmicus; Anterior segment inflammation; Diffuse posterior uveitis and choroiditis; Sympathetic ophthalmia; Keratitis; Allergic conjunctivitis; Optic neuritis; Chorioretinitis; Iritis and iridocyclitis.
Respiratory Diseases: Symptomatic sarcoidosis; Berylliosis; Loeffler's syndrome not manageable by other means; Fulminating or disseminated pulmonary tuberculosis when use concurrently with appropriate antituberculous chemotherapy; Aspiration pneumonitis.
Hematologic Disorders: Idiopathic thrombocytopenic purpura in adults; Secondary thrombocytopenia in adults; Acquired (autoimmune) hemolytic anemia; Erythroblastopenia (RBC anemia); Congenital (erythroid) hypoplastic anemia.
Neoplastic Diseases: For palliative management of: Leukemias and lymphomas in adults; Acute leukemia of childhood.
Edematous States: To induce a diuresis or remission of proteinuria in the nephrotic syndrome, without uremia, or the idiopathic type or that due to lupus erythematosus.
Gastrointestinal Diseases: To tide the patient over a critical period of the diseases in: Ulcerative colitis; Regional enteritis.
Nervous System: Acute exacerbation of multiple sclerosis.
Miscellaneous: Tuberculous meningitis with subarachnoid block of impending block when used concurrently with appropriate antituberculous chemotherapy; Trichinosis with neurologic or myocardial involvement.
Camelon 8: CAMELON is indicated for the treatment in the conditions include: bronchial asthma (usually where other drugs, e.g. sympathomimetics or theophylline, fail to produce the desired result or there is marked bronchial hypersensitivity), allergic rhinitis, urticaria, eczema or dermatitis, acute rheumatic fever, rheumatoid arthritis, acquired (autoimmune) hemolytic anemia, idiopathic thrombocytopenic purpura in adults, myeloblastosis, lymphogranulomatosis, ulcerative colitis, nephrotic syndrome, skin diseases, lupus erythematosus, dermatomyositis.
CAMELON may also be used for suppression of the immune response after transplantations, as an adjuvant in treatment with cytostatic agents or in radiotherapy, for substitution in primary adrenocortical insufficiency and after adrenalectomy.